Hematology/Oncology

• In the Journals

• NIH: Molecular link found between metabolism, breast cancer

• Endocrine Today, March 2013
• Researchers from the National Cancer Institute have identified a protein linked to diabetes and obesity that could be a factor in the development of...More »

• In the Journals

• Spin and bias common in breast cancer studies

• HemOnc Today, March 25, 2013
• Spin and bias are prevalent in a high percentage of published studies about randomized, clinical trials of breast cancer treatments, according to research...More »

• In the Journals

• Sequential docetaxel improved OS, DFS

• HemOnc Today, March 25, 2013
• Sequential docetaxel-doxorubicin chemotherapy significantly improved OS compared with a concurrent regimen among a cohort of patients with node-positive...More »

• In the Journals Perspective

• BRCA1/2 mutation associated with early menopause

• HemOnc Today, March 25, 2013
• Carriers of the BRCA1/2 mutation entered menopause 3 years earlier than noncarriers, according to results of a cross-sectional study.
  The finding could...More »

• Cover Stories Perspective

• Study results renew debate over value of mammography

• HemOnc Today, February 10, 2013
• Mammography has only marginally reduced the rate at which women present with advanced breast cancer and has had minimal effect on the rate of death from...More »

• Cover Stories

• Whole-genome sequencing yields knowledge, hope for future of cancer care

• HemOnc Today, February 25, 2013
• Compared with other disciplines of scientific discovery, cancer genomics is in its infancy.
  However, emerging data from comprehensive cancer genome...More »

• US cancer screening rates drop

• HemOnc Today, February 25, 2013
• Cancer screening rates declined in the United States during the past decade, and levels are less than optimal for many types of malignancies, according to...More »

• In the Journals

• Family history linked to contralateral breast cancer risk

• HemOnc Today, March 10, 2013
• Women aged younger than 45 years with a family history of breast cancer carried a 2.5-fold risk for contralateral disease, according to results of a...More »

• In the Journals Perspective

• Retinoblastoma, PTEN may predict DCIS progression to invasive breast cancer

• HemOnc Today, February 10, 2013
• Loss of retinoblastoma immunoreactivity was associated with a nearly threefold risk for an ipsilateral breast event in women with ductal carcinoma in...More »

• In the Journals

• Cisplatin-based chemotherapy conferred better outcomes than capecitabine-based regimen

• HemOnc Today, February 25, 2013
• Cisplatin-based chemotherapy appeared superior to a capecitabine-based regimen in first-line treatment of metastatic triple-negative breast cancer,...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!